aged 40-80 years as of time of randomization.

two or more medication dispensings for any prescription medication from a kp outpatient pharmacy during the baseline year.

flagged in kp's databases as having either diabetes or atherosclerotic cardiovascular disease(defined as coronary artery disease, peripheral vascular disease, or a history of atherosclerotic stroke)

continuous membership in kp for the 12 months prior to randomization.

willing to participate in the study.

evidence in the emr of allergy or intolerance to statins, ace inhibitors/arbs,or aspirin

use of warfarin or other antiplatelet agents for which aspirin use is contraindicated

end-stage renal disease or other conditions for which ace inhibitor or arb use is contraindicated

use of medications for which use of statins is contraindicated